MedTrace Logo

Multimodal Analgesia Methods in Patients Undergoing IPACK Block in Knee Arthroplasty

NCT04213287 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2019-12-30

No results posted yet for this study

Summary

A comparison of two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) - in patients undergoing total knee arthroplasty. dexketoprofen and paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).

Conditions

  • IPACK Block Multimodal Analgesia
  • Postoperative NRS Scores

Interventions

DRUG

Dexketoprofen Trometamol

Drug: Dexketoprofen Trometamol oral tablet

OTHER

spinal anesthesia

Drug: heavy bupivacaine 2,5 ml 0,5%

OTHER

IPACK

Drug: bupivacaine 20 ml 0,025%

OTHER

PAI

Drug: bupivacaine 30 ml 0,025%

OTHER

Adductor canal block

Drug: bupivacaine 20 ml 0,025%

Sponsors & Collaborators

  • Ankara Diskapi Training and Research Hospital

    lead OTHER

Principal Investigators

  • Ilkay MD Baran Akkuş, MD · Diskapi Yildirim Beyazit Training Education Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-23
Primary Completion
2020-03-01
Completion
2020-03-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04213287 on ClinicalTrials.gov